WCG’s Activation Intelligence Targets the Document Conflict That Quietly Kills Your Startup Timeline
WCG's new Activation Intelligence tool claims to cut 20+ hours of rework per study launch by catching document conflicts...
WCG's new Activation Intelligence tool claims to cut 20+ hours of rework per study launch by catching document conflicts...
WCG's Activation Intelligence saves 20+ hours per study activation. Here's what that number means for site startup budgets and...
nPhase's AI clinical data platform promises smarter trial design, but before sponsors add another vendor, the activation-cycle math deserves...
Fortrea's $45M acquisition of Worldwide Clinical Trials' early-phase division reshapes Phase I site networks and vendor contracts for sponsors...
Fortrea's $45M buy of Worldwide Clinical Trials' Early Phase Services unit means active sponsors face contract novation, lab method...
Aprea's APR-1051 early signals are forcing a rapid site expansion—here's what the enrollment acceleration actually costs at the operational...
A sponsor's mid-study clinical system migration lands on sites first: reconciliation work, documentation risk, and monitoring gaps nobody budgeted....
Merck and SCRI's Accelero™ collaboration targets community oncology enrollment, but the real test is whether 200+ sites can execute...
Curavit's acquisition of Lindus Health CRO assets combines 1,000+ global sites with DCT infrastructure—but site teams absorb the operational...
59% of sites report recruitment blocked by process inefficiencies—the bottleneck isn't patient supply, it's the workflow that never gets...